In an ambitious move to widen access to its medical products, Pfizer plans to provide nearly two dozen patent-protected medicines and vaccines, which are already available in the U.S. or European Union, at not-for-profit prices to 45 poor countries.
Under the initiative, Pfizer will start shipping its products — including its Covid-19 vaccine and antiviral pill — to Rwanda, Ghana, Malawi, Senegal, and Uganda later this year, although the effort will eventually focus on 27 low-income countries and another 18 lower-middle-income countries, most of which are located in Africa. Also on the list are Haiti, Bangladesh, and Tajikistan.
The 23 medicines and vaccines to be made available are used to treat infectious diseases, cancers, and rare and inflammatory diseases. And as the company launches new products, these will also be included in the program on a not-for-profit basis, which means the countries would be able to purchase the drugs and vaccines at substantially lower prices than elsewhere.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
